The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection
about
p53 Activation following Rift Valley fever virus infection contributes to cell death and viral productionThe Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and ReleasePhleboviruses and the Type I Interferon ResponseComplete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common AncestryA Shared Transcription Termination Signal on Negative and Ambisense RNA Genome Segments of Rift Valley Fever, Sandfly Fever Sicilian, and Toscana VirusesRNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever virusesRift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells.A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells.Characterization of the Uukuniemi virus group (Phlebovirus: Bunyaviridae): evidence for seven distinct speciesRift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function.Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSsMolecular biology of rift valley Fever virusRift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and preventionTissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.Rift valley fever: recent insights into pathogenesis and preventionThe pathogenesis of Rift Valley fever.Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infectionThe Rift Valley Fever virus protein NSm and putative cellular protein interactionsThe Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts.Efficient cellular release of Rift Valley fever virus requires genomic RNA.The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging.Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes.Gouleako virus isolated from West African mosquitoes constitutes a proposed novel genus in the family BunyaviridaeUsing reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy.Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein.NSm protein of Rift Valley fever virus suppresses virus-induced apoptosisSingle-cycle replicable Rift Valley fever virus mutants as safe vaccine candidatesRift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals.Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.Vector competence of Aedes vexans (Meigen), Culex poicilipes (Theobald) and Cx. quinquefasciatus Say from Senegal for West and East African lineages of Rift Valley fever virusMinigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever virusesMolecular biology and genetic diversity of Rift Valley fever virusN-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN.Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression.Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs geneDevelopment of a RVFV ELISA that can distinguish infected from vaccinated animals.
P2860
Q24319790-7EF822A5-3F16-4B3C-8B07-9FAE4451F131Q26700101-85D59D4F-FB46-4486-A3B3-A5C97D3BC24EQ26747457-8743EC88-D15C-4FB6-AC39-CA2EC90909C4Q27478367-7C4C432E-BD1C-463E-B63C-8CDC551BCDB3Q27480356-D126E1D0-E096-4CD4-A9B4-A845EAFD307FQ27487321-159BE545-C745-4CE1-82BE-F07C00D7B5CFQ31149260-C94E137E-0BD1-44C9-B2CF-4A37BE7DEB4EQ33316823-49D72860-B81E-46E7-883A-CBCEE36DF5B7Q33405078-ADF6EDC1-E1A5-4CEC-B882-67D06F7C218EQ33406230-512C8129-33BE-4D14-B9C0-ED11671CAB83Q33558533-C0E1DEA8-5406-4EF4-85A5-EB57192903B3Q33570326-3CACE883-0E21-4158-B3ED-FE23EE5688B4Q33617793-D4AA8BC5-6069-4C69-AA90-209FED4F4891Q33705717-B7331593-297C-4CAB-8730-5258B8DE4136Q33886954-5C74D1C8-3EEA-4493-A217-E307B1042A73Q33960690-5CEB1F91-8794-4675-89B0-5740E1F39A2AQ34097995-412B13D9-486B-4371-B905-071D29DB45F2Q34174444-7851DD0D-ACCB-4357-AC70-7FA686474F39Q34191969-F9199CD5-C25E-47DB-BE44-829B0934B516Q34221766-B21B1682-1742-448C-BA7D-67CB5B244C2CQ34260234-B9EC77E7-B15A-4BD0-902A-747E574228BBQ34354086-6A97CABB-7287-4BB8-9ED8-E3FF2979969EQ34440401-630EEBF6-09B3-42E4-B8A8-AD2698B4531CQ34704620-8773CE38-D76E-4D22-BEA3-0D73CAC19712Q35097103-D39BB593-E3A4-418A-B51D-CA35337311C3Q35097798-41A25DD8-E47E-40A6-B8F0-B061E380AA8EQ35192825-7D89188B-6EF8-4555-90BE-2CDF35E51D19Q35841573-85D01E73-F663-4692-AC85-D3754C13625FQ35857234-6DE530AA-EBBA-417F-9F42-1ADCA4C6AD26Q36315241-727A187F-C309-43F3-80F9-1B99D90F3776Q36326847-B1A6F436-3B50-4E1F-A153-B6550912FC23Q36484009-91C6D9F8-4F06-4246-800E-B43F66D2F45FQ36501630-5F8BB36F-03A7-475F-BCAF-0D8CADC454D9Q36599998-5BB9C846-91F9-4A2A-B92F-2A4F72FA018CQ36650409-34233FBD-E162-407D-8CD2-3098980D0150Q36652695-E9417583-E4DD-4C33-A2E4-FE41319D0E35Q36947068-7AAB06A6-14BE-456B-A7B9-E517A6B63674Q37049951-38DF40EB-4C5C-48B8-9637-432B23EC728EQ37252699-F072209A-40D3-4A8D-9046-27B63018F7FDQ37321966-6B6A1453-F2EE-429B-98D0-C2FA6F67D9AB
P2860
The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The NSm proteins of Rift Valle ...... ion, replication and infection
@ast
The NSm proteins of Rift Valle ...... ion, replication and infection
@en
The NSm proteins of Rift Valle ...... ion, replication and infection
@nl
type
label
The NSm proteins of Rift Valle ...... ion, replication and infection
@ast
The NSm proteins of Rift Valle ...... ion, replication and infection
@en
The NSm proteins of Rift Valle ...... ion, replication and infection
@nl
prefLabel
The NSm proteins of Rift Valle ...... ion, replication and infection
@ast
The NSm proteins of Rift Valle ...... ion, replication and infection
@en
The NSm proteins of Rift Valle ...... ion, replication and infection
@nl
P2093
P2860
P3181
P1433
P1476
The NSm proteins of Rift Valle ...... ion, replication and infection
@en
P2093
Brian H Bird
Cesar G Albariño
Sonja R Gerrard
P2860
P304
P3181
P356
10.1016/J.VIROL.2006.09.035
P407
P577
2007-03-15T00:00:00Z